CMS finalizes changes to organ procurement oversight and service-area transitions

Revision 1 · Health policy · United States · Record prepared

Prepared through Iliyn’s AI-assisted editorial workflow. Source statements are not independent audits of underlying events.

An October 30 CMS final rule clarifies organ procurement organization oversight, competition, appeals and continuity requirements when service areas change operators.

What the record says

The Centers for Medicare & Medicaid Services announced a final rule October 30 revising oversight procedures for organ procurement organizations, which coordinate deceased organ donation and recovery.

The rule clarifies certification, competition and appeals procedures. It defines unsafe practices that can support urgent decertification and requires organizations to maintain policies for identifying, investigating and preventing adverse events during donation.

Outgoing organizations must cooperate with successors, and incoming organizations must submit transition plans and progress reports. CMS says these requirements support continuity for patients and donor families.

The agency’s fact sheet says the rule retains the existing focus on donation and transplantation outcome measures and the tier structure used in recertification decisions.

Source details and supporting locations.

Practical next step

Patients, donor families and providers can review CMS’s fact sheet for the final rule’s oversight and transition provisions.

Limits and what is not established

These are regulatory changes described by CMS. The announcement does not guarantee an individual transplant or establish an immediate patient action deadline.

Sources checked October 31, 2026. Later notices may change instructions or arrangements.

Original sources

Centers for Medicare & Medicaid Services: original information

Corrections and history

Read correction history

Analytics is off unless you choose to accept. Privacy and contact